Across the Nutraverse: FDA explores expanded supplements scope, Herbalife-Bioniq, energy drinks in China
This week's "Across the Nutraverse" covers the FDA's public meeting on expanding the scope of dietary supplement ingredients, prompting debate on defining "dietary substance" to include novel scientific advances. Herbalife acquired personalized nutrition firm Bioniq for up to $150 million to bolster its tailored wellness offerings globally. Additionally, China's Eastroc Beverage reported significant growth in 2025, driven by surging demand for energy and sports drinks as consumption shifts from occasional to habitual use.
SteelPeak Wealth LLC Sells 200,000 Shares of Herbalife Ltd $HLF
SteelPeak Wealth LLC reduced its stake in Herbalife Ltd (NYSE:HLF) by 44.4% in the fourth quarter of the previous year, selling 200,000 shares and now holding 250,000 shares valued at approximately $3.22 million. This comes as Herbalife reported Q4 EPS of $0.45, missing consensus estimates, but revenue of $1.28 billion exceeded expectations and grew 6.3% year-over-year. The company currently has a "Moderate Buy" consensus rating from analysts, with an average target price of $17.75.
Herbalife to Announce First Quarter 2026 Results on May 6
Herbalife Ltd. (NYSE: HLF) will release its first quarter 2026 financial results after market close on Wednesday, May 6, 2026. Senior management will host an audio webcast and conference call to discuss results at 5:30 p.m. ET on the same day. The earnings release and supplemental materials will be available on Herbalife's investor relations website.
Here's why Herbalife Ltd (HLF) is a strong value stock
This article from MSN discusses why Herbalife Ltd (HLF) is considered a strong value stock.
Herbalife Nutrition Strengthens Global Distribution In Russell 1000 Index
Herbalife (NYSE:HLF) is reinforcing its global distribution network and market presence, aligning its operations with the Russell 1000 Index. The company utilizes a multi-level distribution model to deliver its nutrition and wellness products worldwide. This strategy emphasizes Herbalife's focus on broad market reach and product accessibility.
Herbalife to acquire Bioniq for personalized wellness
Herbalife Ltd. is set to acquire assets from Bioniq, a U.K.-based personalized supplements company, to advance its vision of becoming a technology-enabled, data-driven health and wellness platform. The acquisition will allow Herbalife to expand its personalized nutrition offerings globally, leveraging Bioniq's patented personalization engine and database of biomarkers. The $55 million transaction, which includes an initial payment and contingent payments based on future performance, is expected to close in the second quarter of 2026.
Herbalife Buys Assets of U.K. Firm for $55 Million
Herbalife Ltd. has acquired assets from London-based personalized supplements company Bioniq for $55 million, aiming to enhance its personalized nutrition program offerings. This acquisition, combined with previous purchases, is part of Herbalife's strategy to expand personalized wellness on a global scale. Despite the strategic move, Herbalife's shares dropped following the announcement, though the company plans to leverage Bioniq's technology and its global distributor network.
Herbalife acquires personalized nutrition firm Bioniq in $150 million deal
Herbalife has acquired personalized nutrition firm Bioniq in a deal valued at up to $150 million. This acquisition aims to expand Herbalife's tailored nutrition offerings by integrating Bioniq's science-driven personalization platform into its global infrastructure. The deal, expected to close in Q2 2026, will allow Bioniq's personalized supplements to be offered through Herbalife's independent distributors in select countries later this year.
Herbalife Acquires Bioniq Assets To Expand Personalization
Herbalife Ltd. has announced its acquisition of certain assets from UK-based Bioniq, including its personalization engine and biomarker database, for $55 million in base payments and up to $95 million in contingent consideration. The acquisition, expected to close in Q2 2026, aims to enhance Herbalife's personalized supplement offerings through its global network, starting in Europe and the U.S. This move expands Herbalife's capabilities in personalized nutrition.
Herbalife to Expand Its Personalized Nutritional Supplement Capabilities Through Planned Acquisition of Bioniq
Herbalife Ltd. announced its intent to acquire certain assets from Bioniq, a UK-based personalized supplements company, for $55 million plus potential contingent payments of up to $95 million. This acquisition aims to enhance Herbalife's personalized nutrition offerings by integrating Bioniq's patented personalization engine and biomarker-driven formulas, aligning with Herbalife's vision to become a technology-enabled health and wellness platform. The transaction is expected to close in Q2 2026, with personalized supplements becoming available through Herbalife distributors in select countries later this year.
Herbalife to Expand Its Personalized Nutritional Supplement Capabilities Through Planned Acquisition of Bioniq
Herbalife Ltd. announced an agreement to acquire certain assets from Bioniq, a UK-based personalized supplements company, to enhance its technology-enabled, data-driven health and wellness platform. The acquisition will allow Herbalife to offer a broader range of personalized nutritional supplements, leveraging Bioniq's patented personalization engine and database of biomarkers. Cristiano Ronaldo, a long-time user and shareholder, supports the move, emphasizing the importance of personalized nutrition for performance.
If You Invested $1,000 in Herbalife (HLF)
This article analyzes the historical performance of a $1,000 investment in Herbalife (HLF) over various periods, showing significant returns in the last year but substantial losses over 5 and 10 years. It also provides a detailed company overview of Herbalife, covering its business model, product focus, geographic reach, R&D, digital initiatives, and community programs. The article concludes with financial data, risk factors, and frequently asked questions regarding HLF's investment returns compared to the S&P 500.
Herbalife Acquires Bioniq Assets Worth 55 Million US Dollars, Strengthening Personal Nutrition Business
Herbalife Ltd. has acquired assets from the British personal supplement company Bioniq for $55 million, with potential additional payments up to $95 million. This acquisition aims to strengthen Herbalife's data-driven nutrition business by integrating Bioniq's personalized supplement technology, which uses biomarker data and health history to create tailored nutritional formulations. The move is expected to expand Herbalife's global reach in personalized wellness solutions, with Bioniq products becoming available through its distributors in Europe and the US by late 2026.
Herbalife to acquire Bioniq to expand personalised nutrition capabilities
Herbalife is set to acquire UK-based Bioniq, a personalized supplements company, to enhance its capabilities in data-driven personalized nutrition. The deal, valued at up to $150 million including contingent payments, aims to combine Bioniq's biomarker-based formulations with Herbalife's global distribution network. High-profile figures like Cristiano Ronaldo, who is both an Herbalife and Bioniq user, endorsed the acquisition, highlighting the importance of tailored nutrition.
Herbalife to acquire Bioniq personalized supplement assets for $55M
Herbalife Ltd. announced its agreement to acquire certain assets from Bioniq, a UK-based personalized supplement company, for $55 million, including an initial $10 million payment and up to $95 million in contingent payments. This acquisition, expected to close in Q2 2026, aims to expand Herbalife's personalized wellness offerings and follows recent strong financial performance and strategic investments.
Vanguard (HLF) Amendment Shows 0 Shares; Subsidiaries to Report Separately
Vanguard Group filed an amended Schedule 13G/A for Herbalife Ltd (HLF), reporting 0 beneficial shares due to an internal realignment effective January 12, 2026. This realignment, referencing SEC Release No. 34-39538, means certain subsidiaries and business divisions will now report their beneficial ownership separately. The filing is an administrative disclosure, not indicating a trading event, and market observers should look for separate filings from Vanguard's disaggregated entities to understand their holdings.
Herbalife Acquires Bioniq Assets
Herbalife Ltd. has announced its acquisition of certain assets from UK-based personalized supplement company Bioniq for an initial $55 million, with potential contingent payments up to $95 million. This move aims to expand Herbalife's personalized nutritional supplement offerings, complementing previous acquisitions and leveraging Bioniq's patented personalization engine. Cristiano Ronaldo, a shareholder in Bioniq and a Herbalife partner, supports the acquisition, emphasizing the importance of personalized nutrition for optimal performance.
ZAWYA-PRESSR: Bioniq announces planned acquisition by Herbalife
Bioniq, a personalized supplement company using blood biomarker analysis, announced its planned acquisition by Herbalife for $55 million, with potential additional payments up to $95 million based on future performance. This acquisition will enable Bioniq to scale its science-driven personalized supplementation platform globally through Herbalife's extensive infrastructure and market presence. Vadim Fedotov, Bioniq's founder, will join Herbalife's leadership team, aiming to accelerate product innovation and enhance customer experience with a data-driven approach to health.
Bioniq announces planned acquisition by Herbalife
Herbalife announced its planned acquisition of Bioniq, a personalized supplements company, in a deal valued at up to $150 million. The acquisition will allow Bioniq to scale its science-driven platform globally through Herbalife's extensive infrastructure, accelerating product innovation and enhancing customer experience. Vadim Fedotov, Bioniq's founder, and key team members will join Herbalife's leadership.
Herbalife to Expand Its Personalized Nutritional Supplement Capabilities Through Planned Acquisition of Bioniq
Herbalife Ltd. announced its intention to acquire certain assets from Bioniq, a UK-based personalized supplements company, to further its vision of becoming a technology-enabled, data-driven health and wellness platform. The acquisition will expand Herbalife's ability to offer personalized nutritional supplements, combining Bioniq's patented product personalization engine with Herbalife's global manufacturing and distribution network. The transaction, valued at $55 million with potential contingent payments up to an additional $115 million, is expected to close in the second quarter of 2026.
Herbalife Ltd stock draws attention amid fresh Asia wellness research developments
Herbalife Ltd is drawing investor interest due to new research highlighting the booming wellness market in Asia, where its nutrition products are well-positioned for growth. The company's direct-selling model provides an efficient way to penetrate these diverse markets, particularly leveraging e-commerce and social selling. US investors can find a familiar entry point with Herbalife's NYSE listing and California headquarters, offering a diversified portfolio with exposure to high-growth Asian markets.
Herbalife Ltd stock draws attention amid fresh Asia wellness research release on March 25, 2026
Herbalife Ltd (HLF) is attracting investor attention due to new research released on March 25, 2026, from Hong Kong, highlighting increased demand for health and wellness products in Asia. This research is expected to boost Herbalife's direct-selling nutrition sector, especially in high-growth regions, and is timely given broader interest in resilient wellness stocks. US investors are closely examining the implications of these international findings on the NYSE-listed stock, particularly regarding distributor potential and volume growth amidst shifting consumer trends.
Asia Pacific Consumers Lack Confidence to Achieve Economic Goals - Herbalife Survey
A Herbalife survey reveals that only 43% of Asia Pacific consumers feel empowered to improve their economic well-being, and just one-third are confident in achieving their financial goals in the next year. In response, many plan to reduce non-essential spending, invest, or start businesses. The survey also highlights a strong correlation between health and economic empowerment, with younger generations showing more optimism in both areas.
Herbalife (NYSE:HLF) Shares Pass Above 200-Day Moving Average - Here's What Happened
Herbalife (HLF) shares recently crossed above their 200-day moving average, reaching $14.85 with a closing price of $14.6430, signaling a bullish technical trend. Analyst sentiment has improved, resulting in a "Moderate Buy" average rating and a $17.25 price target. While quarterly revenue of $1.28 billion exceeded expectations, EPS missed slightly at $0.45, yet the company maintains a low P/E ratio of 6.66.
Herbalife Nutrition Ltd. (NYSE: HLF) Q4 2025 earnings call transcript
This entry is a placeholder for the Q4 2025 earnings call transcript of Herbalife Nutrition Ltd. (NYSE: HLF). The full content of the transcript is not provided in this entry.
Is Herbalife’s Earnings Beat and Personalized Nutrition Push Reshaping the Investment Case for HLF?
Herbalife reported better-than-expected quarterly revenue growth and adjusted EBITDA, driven by a push into personalized nutrition and digital tools, including Cristiano Ronaldo's endorsement of Pro2col. Despite this positive earnings beat, the stock's immediate drop reflects ongoing investor concerns about the company's significant debt and softer net income trends. Analysts have varying forecasts for Herbalife's future performance, with some more cautious than the company's growth narrative.
Herbalife Ltd. (HLF) Stock Price Prediction: Today, Tomorrow, Next Week
This article provides a short-term and monthly stock price prediction for Herbalife Ltd. (HLF) based on technical analysis. It forecasts a slight decline for HLF in the immediate future, with an anticipated average price of $14.61 for tomorrow and a range of $14.81 to $18.1 for the upcoming week. The analysis projects a 4.21% drop over the next month, targeting $14.1.
How Herbalife Ltd. (HLF) Affects Rotational Strategy Timing
Herbalife Ltd. (HLF) exhibits weak near and mid-term sentiment but maintains a strong long-term outlook. AI-generated trading strategies are provided, including position trading, momentum breakout, and risk hedging, with specific entry, target, and stop-loss levels. The analysis highlights an exceptional risk-reward short setup and indicates that a mid-channel oscillation pattern is in play.
Herbalife Ltd (HLF) misses Q4 earnings and revenue estimates
Herbalife Ltd (HLF) reported its Q4 earnings, which fell short of analyst estimates for both earnings and revenue. This financial performance indicates a challenging period for the company.
Herbalife Ltd (HLF) misses Q4 earnings and revenue estimates
This article reports that Herbalife Ltd (HLF) missed its Q4 earnings and revenue estimates. Further details about the financial performance or reasons for the miss are not provided in this entry.
Herbalife Nutrition Ltd. (NYSE: HLF) Q4 2025 earnings call transcript
This article is a transcript of the Q4 2025 earnings call for Herbalife Nutrition Ltd. (NYSE: HLF). It would detail the company's financial performance, operational highlights, and future outlook as discussed by management during the call.
HLF SEC Filings - Herbalife 10-K, 10-Q, 8-K Forms
This page provides comprehensive access to Herbalife (HLF) SEC filings, including 10-K, 10-Q, and 8-K reports, offering detailed insights into the company's operations, financials, and governance. It features AI-powered summaries for quick understanding of key regulatory documents and real-time updates on new filings. Recent documents highlight ownership stakes by investment firms, insider stock purchases and grants, and the company's Q3 2025 earnings report.
HLF SEC Filings - Herbalife 10-K, 10-Q, 8-K Forms
This page provides access to detailed SEC filings for Herbalife Ltd. (HLF), including 10-K annual reports, 10-Q quarterly reports, and 8-K material event filings. It highlights recent insider trading activities with specific details on stock appreciation rights and restricted stock units awarded to executives and leadership, including the CEO, CFO, COO, CCO, and Chairman. The platform also includes AI-powered summaries of these filings to help investors understand key points and implications, alongside information on Herbalife's business model and financial performance for 2025.
Long Focus Capital Management LLC Sells 855,000 Shares of Herbalife Ltd $HLF
Long Focus Capital Management LLC significantly reduced its stake in Herbalife Ltd (HLF) by selling 855,000 shares, bringing its total holding to 3.5 million shares worth $29.54 million. Despite this reduction, Herbalife remains a "Moderate Buy" according to analysts, with an average price target of $16.60, and has recently seen several analyst upgrades. The company reported mixed Q3 results with EPS missing estimates but revenue exceeding expectations, and its stock currently trades with a market capitalization of $1.58 billion.
Silymarin Market Is Going to Boom Rapidly | BASF SE • Herbalife Nutrition Ltd. • Indena S.p.A
Coherent Market Insights has released a comprehensive report titled "Silymarin Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2026-2033." The report offers an in-depth analysis of the market's competition, geographic distribution, and growth potential, encompassing industry performance, critical success factors, risk assessment, and projected returns. It highlights key players like BASF SE, Herbalife Nutrition Ltd., and Indena S.p.A., and segments the market by applications such as Pharmaceuticals, Nutraceuticals, and Cosmetics, providing valuable insights for stakeholders.
Invenomic Capital Management LP Invests $3.55 Million in Herbalife Ltd $HLF
Invenomic Capital Management LP has acquired a new stake of 420,630 shares in Herbalife Ltd, valued at approximately $3.55 million, representing about 0.41% of the company. Analyst sentiment for Herbalife is generally positive with a "Moderate Buy" consensus and an average price target of $16.60. Despite missing EPS estimates, Herbalife's Q3 revenue of $1.28 billion exceeded expectations, demonstrating year-over-year growth.
92,138 Shares in Herbalife Ltd $HLF Acquired by Cinctive Capital Management LP
Cinctive Capital Management LP has acquired a new stake of 92,138 shares in Herbalife Ltd (HLF) during the third quarter, valued at approximately $778,000. This investment represents about 0.09% of Herbalife's ownership at quarter-end. Herbalife recently reported mixed Q3 results with an EPS miss but a revenue beat, and currently holds a "Moderate Buy" consensus rating among analysts.
Herbalife Ltd. Experiences Evaluation Revision Amidst Mixed Market Indicators and Performance Trends
Herbalife Ltd. has undergone an evaluation revision due to fluctuating stock prices, currently at $15.39. While the company significantly outperformed the S&P 500 over the past year with a 90.71% return, its longer-term returns face challenges. Technical indicators present a mixed outlook, with some showing bearish signals and others bullish trends, reflecting the complex market dynamics Herbalife navigates.
Herbalife Ltd. Hits Day High with 7.95% Surge in Strong Intraday Performance
Herbalife Ltd. saw a 7.95% surge, reaching an intraday high of USD 16.78, despite a 13.2% decline over the past week. The stock has demonstrated impressive annual growth of 88.28% against the S&P 500's 17.78% gain, but faces challenges including negative book value and declining long-term operating profit. Herbalife's current market capitalization is USD 2,263 million, placing it in the small-cap category.
[ARS] HERBALIFE LTD. SEC Filing
This article announces an ARS SEC filing by Herbalife Ltd. (HLF), with a low impact and neutral sentiment. The filing, dated March 17, 2026, concerns an ARS document for the company. The article also provides recent news and SEC filings related to Herbalife, along with key stock data.
Herbalife Continues Its Commitment to the LA Galaxy Special Olympics Unified Team in 2026
Herbalife has renewed its support for the LA Galaxy Special Olympics Unified Team for the 2026 season, serving as the official nutrition partner and providing elite resources. This partnership gives Special Olympics athletes access to professional-level nutrition and training, including a signing ceremony attended by LA Galaxy players and staff. The initiative, supported by the Joint Community Partnership Fund, aims to promote inclusivity and athletic development through the power of sport.
Herbalife (HLF) Debt Refi and Ronaldo Tie-Up: Signal of Strength or Masking Core Strains?
Herbalife (HLF) recently reported strong Q4 2025 earnings, announced a $1.55 billion debt refinancing plan, and highlighted Cristiano Ronaldo's investment in Pro2col, a technology linked to the company. These positive developments occur despite ongoing challenges such as declining quarterly sales volumes and falling earnings per share. The article questions whether these recent events indicate true strength or merely mask underlying business pressures, with the refinancing potentially offering short-term financial flexibility but not necessarily resolving long-term demand and earnings issues.
Should Value Investors Consider Purchasing Shares of Herbalife Ltd (HLF)?
Herbalife Ltd (HLF) is presented as a compelling value investment, holding a Zacks Rank #2 (Buy) and an "A" grade for Value. The article highlights HLF's attractive price-to-earnings (P/E) ratio of 4.21 and price-to-cash-flow (P/CF) ratio of 2.12, both significantly lower than industry averages, suggesting potential undervaluation. This, combined with a positive earnings outlook, positions HLF as a noteworthy consideration for value investors.
Papaya Leaf Extract Market Is Going to Boom Rapidly | Herbalife Nutrition Ltd. • Sunfood Superfoods • HealthAid Ltd
Coherent Market Insights has released a comprehensive report on the Papaya Leaf Extract Market, forecasting its trends, share, size, growth, and opportunities from 2026 to 2033. The report analyzes market competition, geographic distribution, and growth potential, covering industry performance, success factors, risk assessment, and financial analysis. It also identifies major market players such as Herbalife Nutrition Ltd. and Sunfood Superfoods, and segments the market by application in nutraceuticals, pharmaceuticals, food and beverages, cosmetics, and more.
Picton Mahoney Asset Management Acquires New Shares in Herbalife Ltd $HLF
Picton Mahoney Asset Management has initiated a new position in Herbalife Ltd (NYSE:HLF) by acquiring 106,426 shares valued at approximately $898,000 during the third quarter. This move is part of a broader trend, as several other institutional investors, such as Iridian Asset Management and Connor Clark & Lunn Investment Management Ltd., also increased their stakes or started new positions in the company. Herbalife, which trades with a market cap of $1.60 billion and a P/E ratio of 7.03, recently reported revenue up 6.3% year-over-year and holds a "Moderate Buy" consensus analyst rating.
Herbalife Ltd (NYSE:HLF) Receives Average Rating of "Moderate Buy" from Analysts
Analysts have given Herbalife Ltd (NYSE:HLF) an average rating of "Moderate Buy," with a consensus 12-month price target of $16.60. The company recently reported quarterly earnings per share of $0.45, missing estimates while revenue beat expectations at $1.28 billion, increasing 6.3% year-over-year. Herbalife's shares opened at $16.16, and institutional investors have adjusted their holdings in the multi-level marketing company.
Herbalife (NYSE:HLF) Expands Global Nutrition Portfolio Across Russell 1000 Market
Herbalife (NYSE:HLF), a global nutrition, supplement, and wellness product company, is expanding its portfolio within the Russell 1000 market. The company is recognized for its operations and scale, positioning it among large publicly traded entities. Herbalife emphasizes nutrition science, collaborating with experts to develop evidence-based products in the global nutrition, wellness, and dietary supplement industry.
Vanguard Group Inc. Sells 242,053 Shares of Herbalife Ltd $HLF
Vanguard Group Inc. recently decreased its stake in Herbalife Ltd (HLF) by 1.9%, selling over 242,000 shares in Q3, though still retaining a significant 11.81% ownership. Despite this reduction, Wall Street analysts maintain a "Moderate Buy" consensus for Herbalife, with an average price target of $16.60, and some recent upgrades to "Strong Buy." The company reported Q3 EPS of $0.45, slightly below estimates, but saw a 6.3% rise in revenue year-over-year.
Herbalife Ltd. Stock Hits Day Low of $17.73 Amid Price Pressure
Herbalife Ltd. (HLF) saw a significant stock decline, dropping 7.8% to an intraday low of $17.73, contrasting with the S&P 500's modest decrease. Despite a strong 118.74% performance over the past year, the company faces long-term challenges, including a negative book value and low cash flow. Its market capitalization is approximately $2.26 billion, classifying it as a small-cap stock.
Herbalife (HLF) CEO updates Form 4 for 215,033 stock appreciation rights
Herbalife's CEO, Stephan Paulo Gratziani, filed an amended Form 4 to correct the exercise price of 215,033 stock appreciation rights (SARs) previously reported at $10.51, now confirmed at $19.26. These SARs, granted on February 25, 2026, under the 2023 Stock Incentive Plan, will vest in three equal installments on February 25, 2027, 2028, and 2029, contingent on continued service. The amendment clarifies that this is a correction to non-cash equity compensation rather than a new market transaction.
